info@marketresearchfuture.com 📞 +1 628 258 0071(US)  📞 +44 2035 002 764(UK)
Temperature Controlled Packaging for Pharmaceutical Market Research Report - Forecast to 2030

Temperature-Controlled Packaging for Pharmaceutical Market: By Product (Insulated Shippers and Insulated Containers), By Type (Active Systems and Passive Systems), By Temperature Range (Up to 10°C, 10°C to 20°C and More than 20°C), By Payload Capacity (Up to 10 L, 10-20 L, 20-40 L, 40-150 L and More than 150 L), By Type of Use (Single Use and Reusable), By End-Use Industry (Pharmaceutical and Clinical Trial) and By Region - Forecast Till 2030

ID: MRFR/PNT/5724-CR | February 2020 | Region: Global | 170 pages

Temperature Controlled Packaging Pharmaceutical Market Speak to Analyst Request a Free Sample

Market Overview


The global temperature-controlled packaging for pharmaceutical market size had estimated to be valued at a global market sum worth USD USD 34.4 billion during the historic forecast period that had ended in 2019. For the ongoing forecast period of 2021-2028, the global market is projected to reach a global market sum that accounts for a final revenue sum worth USD 80.1 billion by 2028. The global market is projected to be growing at a market CAGR of 18.4 % between the period 2021 and 2028. The temperature-controlled packaging for the pharmaceutical market is driven by the growing demand for the healthcare sector during the forecast period that will be ending in 2028.  The North American market that is home to participating regions like the US and Canada is dominating the regional growth in the healthcare sector. With the increased degree of demand from the US, domination is expected to soar high in comparison to other market regions and strike for a better degree of competition.


COVID 19 Analysis


In 2020, the Temperature Controlled Packaging for pharmaceutical market grew by 4% in terms of value, compared to 2019, amid the obnoxious outbreak of the novel COVID-19 pandemic.  The ongoing demand for temperature-sensitive packaging has increased for the distribution of COVID-19 vaccines across the globe as the spread of the pandemic has been huge and at an alarming rate. The global market companies have developed their packaging system for shipping vaccines, test kits, and other critical medicines that are imperative for meeting the requirements of the patients who have tested positive for the pandemic infection. The temperature-controlled packaging is known to be susceptible to product damage due to rising concerns related to a temperature excursion. The product's efficacy gets compromised with the prevalence of temperature deviation. COVID-19 has accelerated trends in the temperature-controlled packaging solution market and the effects are likely to be felt by the market inventors and experts for the ongoing forecast period that will be ending in 2028. The vaccine manufacturing companies are recorded to have collaborated with temperature-controlled packaging providers to develop customized products for the shipment of vaccines especially for the ongoing forecast period of 2021-2028.


The global temperature-controlled packaging for the pharmaceutical market is likely to enhance its investment and funding to carry on the functioning of the market followed by the rising ability to meet the global target audience that is spread in an array of market locations, especially during the ongoing forecast period. Also, the key market products are understanding the need to develop a wide range which is possible because of the opportunities that are introduced by methods related to mergers and acquisitions in the market. The market investment is also helpful in maintaining a proper flow of the demand and supply chain mechanism of the temperature-controlled packaging for pharmaceutical market share amid the ongoing forecast period of 2021-2028.


Competitive Landscape


The key temperature-controlled packaging for pharmaceutical market players are as follows:



  • Softbox Systems (UK)

  • FedEx Corporation (US)

  • Sofrigam SA (France)

  • Envirotainer AB (Sweden)

  • DGP Intelsius GMBH (UK)


Market Dynamics


Drivers


Biopharmaceuticals or BioPharma products are known to be derived from biological sources like an animal, humans, and microorganisms. Vaccines, enzymes, tissues, gene therapies, and others like cell therapies are some examples of biopharmaceuticals. These products, as a part of the temperature-controlled packaging for the pharmaceutical market, are susceptible to heat, humidity and are hence, required to be stored in low temperatures for shipping and storage.


Vaccines and cell therapies transportation requires a lower temperature movement for the process of shipping. In 2020, due to the outbreak of the COVID-19 pandemic, the demand for the COVID-19 vaccine, cell and others like gene therapies, and other flu vaccines have increased significantly and the same trends are likely to be followed during the ongoing forecast period of 2021-2028. According to stats that have been circulated by Our World, as of April 2020, about only 5% of the overall population have received at least one dose of COVID-19 vaccines and more dose number is likely to be witnessed as the global temperature-controlled packaging for the pharmaceutical market size moves towards the end of the forecast period in 2028.


Restraints


One of the risks involved in the supply of pharmaceutical products includes contamination and this might hamper the temperature-controlled packaging for the pharmaceutical market size from growing as per the predictions that have been laid down for the forecast period that will be ending in 2028. The US Food and Drug Administration (FDA) enjoys the authority to regulate the shipment of products. Regulation is inclusive of 21 CFR 211.150 that talks about distribution procedures of temperature-sensitive products. The World Health Organization (WHO) imposed regulations on the shipment of temperature-sensitive pharmaceutical products across the globe are giving birth to possible market restraints for the global market functioning. The market regulations come under the Good Distribution Practices (GDP) Regulations. The market practices are likely to maintain the efficiency of the product, followed by the regulation that focuses on identifying and minimizing the risks. Managing active and passive shipments for road and air transport for various cold chain points also fall under the category of the WHO regulations.


Technology Analysis


The cold chain processes are known to carry a temperature-sensitive payload. These payloads are functioning at risk of damage and loss due to temperature excursion during shipment. Temperature-sensitive products are primarily a part of the biopharmaceutical industry and hence, are of high importance. The global industry encounters a loss of about USD 35 billion yearly because of the failures in temperature-controlled logistics. The shipment of COVID-19 vaccines and other products inclusive of the cell and gene therapies has increased amid the sudden outbreak of the COVID-19 pandemic in 2020. The temperature-controlled packaging for the pharmaceutical market includes solution providers that are likely to be focusing on developing a platform to improve the real-time visibility across the cold chain for temperature and location of cargos in the global market premises for the forecast period.


Segment Overview


The temperature-controlled packaging for pharmaceutical market share is likely to be enhanced because of the performance of the market segments. The global market has been segmented as follows:


Based on the Type



  • Active Systems

  • Passive Systems


Based on the Usability



  • Single

  • Reuse


Based on the Revenue Type



  • Products

  • Services


Based on the Product



  • Insulated Shippers

  • Insulated Containers

  • Refrigerants


Other products include the following:



  • Pharma

  • Biopharma


Based on the global region



  • North America

  • Europe

  • Asia Pacific (APAC)

  • Middle East & Africa (MEA)

  • South America


Regional Analysis


The global temperature-controlled packaging for the pharmaceutical market is witnessing the patterns and emergence in 5 major participating regions. The North American region had accounted for the largest share of the TCP market in 2020, followed by the APAC region and Europe. The utilization of the market products and services is expected to witness the highest growth in the region during the forecast period that will be ending in 2028. The market in this region is likely to be driven by the presence of global pharma and biopharma industries. Due to the COVID-19 outbreak, the demand for COVID-19 vaccines and other related products for treatment has increased significantly. The supply and distribution of COVID-19 vaccines id further, requiring temperature-controlled packaging solutions. 


Recent Developments



  • In November 2020, one of the prominent market companies - Sonoco Products Company had launched the EOS line of parcel shippers. The product is understood to be a recyclable temperature control packaging system. The product is likely to be made for life science and perishable food products.

  • In November 2020, another market company - Cold Chain Technologies planned to open a new facility in Lebanon, US for the wide distribution of COVID-19 vaccines.

  • In October 2020, Pelican BioThermal LLC took to the international market scale and introduced the new line of Golden Hour One, the new line of products for the military. The product is relatively smaller and is likely to be suitable to carry blood and platelets.

  • In February 2020, Pelican BioThermal LLC announced its acquisition with NanoCool LLC (Albuquerque, New Mexico). The company is likely to be involved in the production of temperature-controlled packaging systems.

  • In January 2020, another market company Sonoco Products Company acquired Thermoform Engineered Quality, LLC from ESCO Technologies, Inc (US). The company is functioning as a manufacturer of thermoformed packaging for health care and other markets.


Report Overview


The temperature-controlled packaging for the pharmaceutical market report contains the discussion of various market aspects that will help the market strike for expansion and growth during the forecast period of 2021-2028. The global market report highlights the basis of the global market segmentation followed by the factors giving rise to major market competition and the recent developments that have been undertaken by the market forces during the period.



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: USD 135.66 Billion
  CAGR   19.2% CAGR (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2019 & 2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Type, Temperature Range, Payload Capacity, Type of Use, End-Use Industry
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Envirotainer AB, Cold Chain Technologies, Sofrigam, Pelican Bio Thermal, Sonoco ThermoSafe, Softbox Systems Limited, va-Q-tec AG, Storopack Hans Reichenecker GmbH, DHL International GmbH, DB Schenker, United Parcel Service of America, Inc. (UPS), and KUEHNE + NAGEL INC.
  Key Market Opportunities

  • Balanced Clinical Trial Processes With An Authentic Data System
  • Government Support
  •   Key Market Drivers

  • Growth In The Pharmaceutical Industry
  • Adoption Of Smarter Cold Chain Technology
  • Increase In R&D Investment In The Pharmaceutical Industry


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The market is likely to grow at a market CAGR of 18.4%.

    The major players are Sonoco ThermoSafe, DB Schenker, Sofrigam, United Parcel Service of America, Inc. (UPS), Softbox Systems Limited, Cold Chain Technologies, Storopack Hans Reichenecker GmbH, KUEHNE + NAGEL INC, Envirotainer AB, DHL International GmbH, Pelican Bio Thermal, and va-Q-tec AG.

    The segments of the temperature controlled packaging for pharmaceutical market, by payload capacity, are Up to 10 L, 20-40 L, 10-20 L, 40-150 L, and More than 150 L.

    The up to 10 L segment is anticipated to expand at 19.2% CAGR.

    The 40-150 L segment is anticipated to mark 9.88% CAGR.

    The segments based on end-use industry are pharmaceutical and clinical trial.

    Global Temperature-controlled Packaging for Pharmaceutical Market- Competitive Landscape


    Market Research Future includes following key players for global Temperature-controlled Packaging for Pharmaceutical Market research study: Envirotainer AB, Pelican Biothermal LLC, Sofrigam, Softbox Systems Limited, Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, and Va-Q-Tec AG and the major logistic companies are DHL International GmbH, Yusen Logistics, Agility, CEVA logistics, DB Schenker, DHL International GmbH, and KUEHNE + NAGEL INC.


    The market share analysis is derived by considering various factors such as financial position, segmental R&D investment, product innovations, corporate strength, product portfolio, strategy analysis, and, key innovations in the market among other factors. The major players holding prominent position in the Market are Sonoco ThermoSafe, Storopack Hans Reichenecker GmbH, Envirotainer AB, Cold Chain Technologies, and Softbox Systems Ltd. among others.


    According to MRFR analysis, Sonoco ThermoSafe is a global giant in temperature assurance packaging for efficient and safe transportation of pharmaceuticals, vaccines, and other temperature sensitive products with 5.2% market share. The company has broad portfolio for other products such as insulated slippers, durable insulated containers, protective packaging and diagnostic. The company has 30 global location (15 ThermoSafe dedicated and 15 Sonoco Protective solution), out of which more than 50 plant sites are in Southeast Asia and 8 sites are in China. The company believes that cash generated from operations will help focus on the development of new products, and new markets, as well as it will help gain customers.


    Storopack Hans Reichenecker GmbH is the second largest company offering nnovative and effective packaging solutions with 3.8% of the total market share. The company has a wide line of offerings, which include flexible protective packaging, temperature controlled protective packaging, customized protective packaging, technical molded parts, which are applicable in automotive, consumer electronics, industry, food, and pharmaceutical industries. It is continuously working on the challenges encountered while offering appropriate solutions and the highest level of services for changing demands of customers.


    Envirotainer AB holds the third largest market share of the market with 2.5%. The company develops and manufactures innovative containers, including validation and testing, services for pharmaceutical products, which require for temperature controlled packaging. It offers services such as the active cold chain containers, and cold chain services which include various subsegments such as technical support, post-shipment analysis, qualification services, shipment set up services, and active cold chain membership. The company focuses on forming partnerships and increasing the number of warehouses based on demand and sales in various regions to gain the maximum number of customers.


    Cold Chain Technologies (CCT) holds the fourth largest market share with 0.7% of the global market. It offers a wide range of cost-effective packaging options for Just in Time (JIT) delivery to the customers. The company includes, standard and custom KoolTemp qualified shipping systems and containers, Koolit refrigerants and PCMs and temperature indicators and loggers. It’s extensive thermal packaging design and manufacturing experience enables it to provide quality focused products and services to clients around the world in markets that include pharmaceutical and biotech manufacturers, third-party logistic (3PL) providers, and specialty pharmacies.


    Softbox Systems Ltd. holds 0.4% of the global market share. The company is involved in the design, development, and production of passive temperature-controlled packaging systems for pharmaceutical companies. Recently, company has made a number of acquisitions of major companies such as Cold Tech Systems, TP3 Global, and Tempack. This will strengthen its portfolio in the future.